{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-061038","form_type":"8-K","ticker":"ABVC","cik":"0001173313","company_name":"ABVC BIOPHARMA, INC.","filed_at":"2023-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.300564+00:00","generated_at":"2026-06-12T21:46:56.921689+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ABVC BioPharma closes $1.75M registered direct offering of common stock and pre-funded warrants","bullets":["Offering of 500,000 shares/pre-funded warrants at $3.50/share to a single institutional investor.","Gross proceeds of $1.75 million before fees; net proceeds for R&D, working capital, and debt repayment.","Wilmington Capital Securities acted as placement agent; offering through existing shelf registration.","Closing occurred July 31, 2023, with all conditions satisfied."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-061038","json":"https://secwatch.observer/filing/0001213900-23-061038.json","markdown":"https://secwatch.observer/filing/0001213900-23-061038.md","text":"https://secwatch.observer/filing/0001213900-23-061038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1173313/000121390023061038/0001213900-23-061038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1173313/000121390023061038/ea182578-8k_abvcbio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T21:46:56.921689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8296f596d68f6a33315831c68606a2a557aa8ee3","claim":"ABVC BIOPHARMA, INC. entered into SPA with a certain institutional investor (effective 2023-07-27).","evidence_excerpt":"the Company entered into certain securities purchase agreement, dated July 27, 2023 (the “ SPA ”), with a certain institutional investor (the “ Purchaser ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1173313/000121390023061038/0001213900-23-061038-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a certain institutional investor"},{"label":"Effective","value":"2023-07-27"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}